ArticleDrug design, development and therapy2025
Bibliometric Analysis of Exosome Research in Spinal Cord Injury (2000-May 2024). Trends, Collaborations, and Emerging Insights.
Article in Drug design, development and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Exosome-based therapies for corneal disorders: current status and future perspectives.MedScience · 2026Review
- Mapping two decades of nanomaterials research in glioblastoma: trends, networks, and translational insights.Naunyn-Schmiedeberg's archives of pharmacology · 2026Review
- Temporal-spatial evolution of tumor habitat analysis: a bibliometric study on research hotspots and trends in medical imaging (2014-2025).Translational cancer research · 2026Article
- The potential mechanisms and regulatory roles of exosomal miRNA in neural repair after spinal cord injury.Frontiers in cellular neuroscience · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Exosomes have emerged as promising therapeutic agents for spinal cord injury (SCI). The present study was conducted to provide a systematic bibliometric analysis of research trends related to SCI and exosomes. Patients and Methods: Publications on exosomes in SCI were identified from the Web of Science Core Collection using specific search criteria. VOSviewer, CiteSpace, and R-based Bibliometrix were employed to visualize collaboration networks and research hotspots. Results: The analysis included 281 publications across 66 countries. The publication numbers were consistently trending upwards, with the United States and China being two of the top producing countries. The top three articles were cited 539, 300, and 254 times, respectively. The analyzed publications were from 153 journals, and the Conclusion: The findings underscore the accelerated exploitation and promise of exosomes as a novel treatment for SCI with significant translational potential through emerging hotspots such as microglia modulation and engineered exosome platforms. The insights gained from this study are important and may be essential for the advancement of exosome-based treatments by researchers and clinicians in the field of spinal cord injury.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.